Amgen Japanese Partner Urges Caution On Tavneos Use

All NewsMay 18, 2026

Amgen partner Kissei advised doctors to avoid new Tavneos use in Japan after FDA liver injury warnings and scrutiny over trial data.

Importance Rank:

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT